| Vieillard-Baron A, Caille V, Charron C, et al.
Reversal of refractory septic shock with drotrecogin alpha (activated). [Journal Article]
Intensive Care Med 2009 Jul; 35(7):1204-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Hodder RV, Hall R, Russell JA, et al.
Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort. [JOURNAL ARTICLE]
Crit Care 2009 May 20; 13(3):R78.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Lorenz BD, Smith TD, Laessig K, et al.
Recombinant activated protein C and risk of bleeding. [Comment, Letter]
Crit Care Med 2009 Jun; 37(6):2141-2; author reply 2142.
Full Citation | Publisher Full Text | Find Related Articles |
| Williams M, Janes J
Recombinant activated protein C and risk of bleeding. [Comment, Letter]
Crit Care Med 2009 Jun; 37(6):2140-1; author reply 2142.
Full Citation | Publisher Full Text | Find Related Articles |
| McRitchie D, Farooq W, Fisher HN
Use of drotrecogin alfa (activated) in a severe acute respiratory syndrome patient with severe sepsis. [Journal Article]
Can J Infect Dis Med Microbiol 2008 May; 19(3):258-9.
Full Citation |
| Huston JM, Eachempati SR, Rodney JR, et al.
Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient. [JOURNAL ARTICLE]
Transpl Infect Dis 2009 Apr 8.
Abstract | Full Citation |
| Berkman S, Weimert NA, Taber DJ, et al.
The use of drotrecogin alfa (activated) in solid organ transplant patients: a case series. [JOURNAL ARTICLE]
Transpl Infect Dis 2009 Apr 17.
Abstract | Full Citation | Find Related Articles |
| Levy M, Levi M, Williams MD, et al.
Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis. [JOURNAL ARTICLE]
Intensive Care Med 2009 Apr 15.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Chan AL, Hsieh HJ, Lin SJ
Pharmacist intervention in activated protein C therapy for severe sepsis: influence on health and economic outcomes. [Journal Article]
Int J Clin Pharmacol Ther 2009 Apr; 47(4):229-35.
Abstract | Full Citation | Find Related Articles |
| Woodward B, Cartwright M
Safety of drotrecogin alfa (activated) in severe sepsis: Data from adult clinical trials and observational studies. [JOURNAL ARTICLE]
J Crit Care 2009 Feb 11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
